Blog
21 December, 2023
The working group led by Farmaindustria holds a new meeting, with the participation of two new pharmaceutical companies. Farmaindustria.es The drive for clinical research in Primary […]
19 December, 2023
Of the €1.395 billion registered in 2022, 60% was devoted to clinical trial development. One out of every eight euros is already spent on basic and […]
11 December, 2023
Farmaindustria participates in the Medical Oncology, Haematology and Oncohaematology Pharmacy Congress ‘Building Bridges’, where data management in biomedical research was discussed. Farmaindustria.es “The proposed Regulation for […]
1 December, 2023
Farmaindustria’s CEO, Juan Yermo, participates in the conference ‘Towards a Comprehensive European Plan: Spain’s involvement with Rare Diseases’, organised by Feder in the Spanish Congress of […]
27 November, 2023
Farmaindustria presents the ‘Guide of good practice recommendations for the promotion of clinical research in Primary Care’, which will bring new treatment opportunities to patients in […]
21 November, 2023
The director of Farmaindustria’s Research Department participates in a round table on the regulation of this project held at the European Parliament Office in Madrid. “For […]
13 November, 2023
The Code of Conduct regulating the processing of personal data in clinical trials approved in 2022 makes it easier for companies and researchers to correctly comply […]
2 November, 2023
The director of Farmaindustria’s Access Department, Isabel Pineros, participates in the XVI International Congress on Rare Diseases: “In recent years we have seen great advances in […]
30 October, 2023
This is demonstrated by a recent study by Professor Frank R. Lichtenberg of Columbia University, which has just been published in the journal Value in Health. […]
24 October, 2023
On World Disease Day, which is celebrated on October 19, Farmaindustria remembers the importance of clinical trials, the previous step for the arrival of innovative treatments […]
17 October, 2023
The document proposes, without the need for a regulatory change, a procedure that would allow the equitable arrival of drugs that meet certain criteria that make […]
11 October, 2023
elglobal.es In a political context with elections called for the European Parliament at the beginning of June 2024 and with Spain holding the presidency of […]
9 October, 2023
Between 2020 and 2022, 446 clinical trials with children and adolescents were conducted in our country, almost half of them focused on rare diseases and 90.4% […]
4 October, 2023
In recent years, the number of applications capable of interacting with patients to prevent, manage or treat diseases has increased, and which can also generate data […]
2 October, 2023
The 7th Congress of Patients’ Organisations, organised by the POP, analyses the application of the new European Regulation on Clinical Trials. Farmaindustria’s director general, Juan Yermo, […]
26 September, 2023
The vast majority of them are aimed at modifying the course of the disease, according to an Iqvia report on the future of R&D. In Spain […]
19 September, 2023
Only 7.5% are carried out in health centres. In order to alleviate this situation, Farmaindustria has presented a programme to promote them in outpatient clinics. Source: […]
14 September, 2023
“We are going to create a favourable environment”. This statement by José Manuel Miñones is the first step towards a roadmap that would highlight the key […]
12 September, 2023
“We must take advantage of the opportunity provided by the Spanish Presidency of the Council of the EU to include health, medicines and the innovative pharmaceutical […]
25 July, 2023
Over the next five years, the number of cancer treatments consisting of more than one drug will double, with 68 authorisations expected to be granted The […]
18 July, 2023
The forum, organised by the Menéndez Pelayo International University (UIMP) and Farmaindustria, will be held on 7 and 8 September in Santander Patient representatives, drug authorities, […]
10 July, 2023
The sector invests 41.5 billion euros in research and directly employs some 840,000 people 300 billion, exports ¤565 billion and contributes ¤175 billion to the EU-27 […]
4 July, 2023
Last year, the sector contributed 313 million euros for organisations and healthcare professionals to participate in research and development activities for new treatments For the eighth […]
27 June, 2023
One out of every three tests carried out in Europe takes place in Spain. Investment has grown by 5.3% annually since 2011, to almost 800 million […]
19 June, 2023
The associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, explained at a forum organised by the POP that work is already underway […]
5 June, 2023
The director of Farmaindustria’s Access Department, Isabel Pineros, explains the situation of these drugs in Spain at a conference organised by the Kronos Foundation, the Hospital […]
30 May, 2023
On 23 May, part of the Distefar team attended the biomedical research technology platform. The opening was a conference by Juan José Vaquero, entitled “Strategy for […]
25 May, 2023
The director of Farmaindustria’s Access department analyses the challenges in the access of these patients to pharmaceutical innovation at a conference of the Spanish Society of […]
22 May, 2023
International Clinical Trials Day commemorates the importance of clinical trials every 20 May Clinical trials advance medicine and address unmet medical needs Source: farmaindustria.es In the […]
11 May, 2023
The Deputy Director General of Farmaindustria, Javier Urzay, recalls that this is a key moment to define the country’s strategy in research to face the new […]
31 October, 2024
Farmaindustria is leading a project to bring clinical trials to primary care to help decentralise this strategy. laopiniondezamora.es ‘Transforming primary care through clinical trials’ was the […]
29 October, 2024
Assessing Europe’s clinical trial ecosystem, produced by Iqvia for Efpia and Vaccines Europe, shows a 22-12% drop in the share of studies on the continent over […]
24 October, 2024
The Extraordinary General Assembly on Thursday unanimously elected the CEO of Amgen Iberia to lead the Association for the next two years. Source: Farmaindustria.es Fina Lladós […]
22 October, 2024
There are currently more than 600 clinical trials underway for children and adolescents in Spain, almost half of them focused on rare diseases. The Spanish Network […]
8 October, 2024
The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. […]
27 September, 2024
The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial […]
26 September, 2024
From R&D to pharmacovigilance to production and incremental innovation, the industry is constantly seeking to maximise risk reduction in medicines. On World Patient Safety Day, WHO […]
24 September, 2024
Artificial intelligence applied to medical research, top technology trend in 2024 according to the World Economic Forum. Farmaindustria.es Artificial intelligence (AI) is a true revolution […]
19 September, 2024
The report highlights the sector’s contribution to the EU’s R&D and trade balance and recognises the worrying trend of Europe losing ground to other regions of […]
17 September, 2024
The Director General of Farmaindustria, Juan Yermo, presents the sector’s potential and challenges on the second day of the 23rd Annual Meeting of the Pharmaceutical Industry […]
30 July, 2024
1 THE BRAND-NAME DRUG COSTS THE SAME AS ITS GENERIC DRUG Farmaindustria.es Brand-name drugs are at the same price as generic drugs in Spain. The […]
23 July, 2024
For the first time, China has overtaken Europe as the creator of new active ingredients, with 25 compared to the 17 of the old continent, and […]
